Phase I dose escalation pharmacokinetic assessment of intravenous humanized anti-MUC1 antibody AS1402 in patients with advanced breast cancer

Overview of attention for article published in Breast Cancer Research, October 2009

Altmetric Badge

Mentioned by

patent: 3 patents

Citations

dimensions_citation: 39 Dimensions

Readers on

mendeley: 48 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

Re-directed immunotherapy

Grant US-11236131-B2

United States of America

Re-directed immunotherapy

Grant US-10287321-B2

United States of America

Immunotherapeutic molecules and uses

Grant US-10106621-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.